High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Nodular Lymphocyte-Predominant Hodgkin Lymphoma

被引：33
|
作者：
Karuturi, Meghan [1 ]
Hosing, Chitra [1 ]
Fanale, Michelle [2 ]
Medeiros, L. Jeffrey [3 ]
Alousi, Amin M. [1 ]
de Lima, Marcos J. [1 ]
Qazilbash, Muzaffar H. [1 ]
Kebriaei, Partow [1 ]
Younes, Anas [2 ]
Khouri, Issa [1 ]
Andersson, Borje S. [1 ]
Champlin, Richard [1 ]
Anderlini, Paolo [1 ]
Popat, Uday [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2013年 / 19卷 / 06期
关键词：
Hodgkin Lymphoma; Autologous stem cell transplantation; Nodular lymphocyte predominant Hodgkin lymphoma; Relapse; Chemosensitive; STUDY-GROUP GHSG; LONG-TERM; MARROW-TRANSPLANTATION; RITUXIMAB; PHASE-2; DISEASE; TRIAL;
D O I：
10.1016/j.bbmt.2013.03.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a distinct subtype of Hodgkin lymphoma that is characterized by unique clinical presentation, histological appearance, and indolent disease course. The recurrent nature of disease provides an opportunity to examine the role of stem cell transplantation in its management. We report here a single-center experience of 26 patients with relapsed NLPHL treated with high-dose chemotherapy and autologous stem cell transplantation between 1990 and 2008. With a median follow-up of 50 months (range, 2-138 months), the 5-year overall and event-free survival were 76% (SE 10%) and 69% (SE 10%), respectively. Our data suggest that high-dose chemotherapy and autologous transplantation should be considered as an option for patients with relapsed NLPHL. (C) 2013 American Society for Blood and Marrow Transplantation.
引用
收藏
页码：991 / 994
页数：4
相关论文
共 50 条
  • [1] High-dose chemotherapy and autologous stem cell transplantation for relapsed or refractory nodular lymphocyte predominant Hodgkin lymphoma
    Akhtar, S.
    Elhassan, T. A. M.
    Edesa, W.
    Rauf, M. S.
    Zahir, M. N.
    Maghfoor, I.
    ANNALS OF HEMATOLOGY, 2016, 95 (01) : 49 - 54
  • [2] High-dose chemotherapy and autologous stem cell transplantation for relapsed or refractory nodular lymphocyte predominant Hodgkin lymphoma
    S. Akhtar
    T. A. M. Elhassan
    W. Edesa
    M. S. Rauf
    M. N. Zahir
    I. Maghfoor
    Annals of Hematology, 2016, 95 : 49 - 54
  • [3] Management of nodular lymphocyte-predominant Hodgkin lymphoma
    Eichenauer, Dennis A.
    Engert, Andreas
    HEMATOLOGICAL ONCOLOGY, 2013, 31 : 47 - 50
  • [4] High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working party
    Akhtar, Saad
    Montoto, Silvia
    Boumendil, Ariane
    Finel, Herve
    Masszi, Tamas
    Jindra, Pavel
    Nemet, Damir
    Fuhrmann, Stephan
    Beguin, Yves
    Castagna, Luca
    Ferrara, Felicetto
    Capria, Saveria
    Malladi, Ram
    Moraleda, Jose Maria
    Bloor, Adrian
    Ghesquieres, Herve
    Meissner, Julia
    Sureda, Anna
    Dreger, Peter
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (01) : 40 - 46
  • [5] Nodular lymphocyte-predominant Hodgkin lymphoma
    Fuchs M.
    Eichenauer D.A.
    Nogová L.
    Diehl V.
    Engert A.
    Current Hematologic Malignancy Reports, 2008, 3 (3) : 126 - 131
  • [6] Nodular lymphocyte-predominant Hodgkin lymphoma
    Savage, Kerry J.
    Mottok, Anja
    Fanale, Michelle
    SEMINARS IN HEMATOLOGY, 2016, 53 (03) : 190 - 202
  • [7] Treatment of nodular lymphocyte-predominant Hodgkin lymphoma
    Eichenauer, Dennis A.
    Eich, Hans Theodor
    Engert, Andreas
    ONKOLOGIE, 2022, 28 (10): : 908 - 913
  • [8] Nodular lymphocyte-predominant Hodgkin lymphoma in children: clinical course, biology, and management
    Gorde-Grosjean, Stephanie
    Guimard, Gregory
    Lambilliotte, Anne
    Coulomb-Lhermine, Aurore
    Montravers, Francoise
    Landman-Parker, Judith
    BULLETIN DU CANCER, 2014, 101 (09) : 881 - 890
  • [9] Modern principles in the management of nodular lymphocyte-predominant Hodgkin lymphoma
    Spinner, Michael A.
    Varma, Gaurav
    Advani, Ranjana H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (01) : 17 - 29
  • [10] Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma
    Borchmann, Sven
    Joffe, Erel
    Moskowitz, Craig H.
    Zelenetz, Andrew D.
    Noy, Ariela
    Portlock, Carol S.
    Gerecitano, John F.
    Batlevi, Connie L.
    Caron, Philip C.
    Drullinsky, Pamela
    Hamilton, Audrey
    Hamlin, Paul A., Jr.
    Horwitz, Steven M.
    Kumar, Anita
    Matasar, Matthew J.
    Moskowitz, Alison J.
    Owens, Colette N.
    Palomba, M. Lia
    Younes, Anas
    Straus, David J.
    BLOOD, 2019, 133 (20) : 2121 - 2129
12345